Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Chronic HBV Infection Study
Clinical Trial Protocol ID
07052903

Clinical Trial Investigator Name
David Van Thiel

Clinical Trial Title

A study of Entecavir in Blacks/African Americans and Hispanics with chronic HBV infection.



Clinical Trial Protocol Description

This study is being done to estimate the proportion of subjects who achieve an HBV DNA < 50 IU/mL (approximately 300 copies/mL) at Week 48 of ETV treatment.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Have a chronic HBV infection
  • Are nucleoside/tide-naïve
  • Are Black/African Americans or Hispanic

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.





Contact Name Doris Yadav
Contact Phone (312) 563-3919
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Infectious Disease Trials
Chronic HBV Infection Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois